AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Over the last 12 months, insiders at AbCellera Biologics Inc. have bought $516,400 and sold $0 worth of AbCellera Biologics Inc. stock.
On average, over the past 5 years, insiders at AbCellera Biologics Inc. have bought $37.36M and sold $197.02M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hayden Michael R (director) — $825,600. Montalbano John S. (director) — $137,400. Lecault Veronique (Chief Operating Officer) — $103,800.
The last purchase of 10,000 shares for transaction amount of $44,600 was made by Montalbano John S. (director) on 2023‑11‑08.
2023-11-08 | Montalbano John S. | director | 10,000 0.0037% | $4.46 | $44,600 | +9.65% | ||
2023-11-06 | Montalbano John S. | director | 20,000 0.0071% | $4.64 | $92,800 | +2.51% | ||
2023-09-22 | Hayden Michael R | director | 20,000 0.0066% | $4.91 | $98,200 | -10.20% | ||
2023-09-12 | Lecault Veronique | Chief Operating Officer | 20,000 0.007% | $5.19 | $103,800 | -11.87% | ||
2023-08-08 | Hayden Michael R | director | 30,000 0.0104% | $5.90 | $177,000 | -20.20% | ||
2023-05-26 | Thermopylae Holdings Ltd. | 10 percent owner | 153,000 0.051% | $6.52 | $997,728 | -26.32% | ||
2023-05-26 | Booth Andrew | Chief Financial Officer | 14,500 0.0051% | $6.85 | $99,325 | -26.32% | ||
2022-12-16 | Thermopylae Holdings Ltd. | director | 85,102 0.0295% | $10.10 | $859,249 | -33.50% | ||
2022-08-19 | Thermopylae Holdings Ltd. | 10 percent owner | 200,000 0.0702% | $11.46 | $2.29M | -19.58% | ||
2022-06-14 | Thermopylae Holdings Ltd. | 10 percent owner | 9,173 0.0029% | $8.05 | $73,842 | +16.48% | ||
2022-06-13 | Thermopylae Holdings Ltd. | 10 percent owner | 54,915 0.0189% | $8.03 | $441,066 | +25.00% | ||
2022-06-06 | Thermopylae Holdings Ltd. | 10 percent owner | 64,545 0.0222% | $7.50 | $483,965 | +33.64% | ||
2022-05-16 | Lecault Veronique | Chief Operating Officer | 200,000 0.057% | $6.34 | $1.27M | +31.24% | ||
2022-05-13 | Thermopylae Holdings Ltd. | 10 percent owner | 300,000 0.1057% | $7.26 | $2.18M | +41.77% | ||
2022-05-12 | Thermopylae Holdings Ltd. | 10 percent owner | 1.41M 0.4723% | $6.41 | $9.02M | +52.76% | ||
2022-05-12 | Booth Andrew | Chief Financial Officer | 85,000 0.0258% | $5.79 | $492,150 | +52.76% | ||
2022-03-04 | Montalbano John S. | director | 10,000 0.0035% | $8.54 | $85,400 | +20.22% | ||
2022-03-01 | Montalbano John S. | director | 20,000 0.0071% | $9.05 | $181,000 | +13.38% | ||
2022-02-28 | Lecault Veronique | Chief Operating Officer | 230,789 0.0808% | $8.66 | $2M | +17.68% | ||
2021-11-11 | Thermopylae Holdings Ltd. | 10 percent owner | 202,960 0.0722% | $14.76 | $3M | -31.79% |
Lecault Veronique | Chief Operating Officer | 2040122 0.7031% | $2.79 | 4 | 1 | <0.0001% |
Hayden Michael R | director | 1323397 0.4561% | $2.79 | 3 | 1 | <0.0001% |
Montalbano John S. | director | 86000 0.0296% | $2.79 | 6 | 0 | <0.0001% |
Thermopylae Holdings Ltd. | 10 percent owner | 56012493 19.3033% | $2.79 | 9 | 1 | +6.49% |
THIEL PETER | director | 10179880 3.5082% | $2.79 | 1 | 0 | <0.0001% |
Hansen Carl L. G. | Chief Executive Officer | 233500 0.0805% | $2.79 | 0 | 1 | |
Booth Andrew | Chief Financial Officer | 153000 0.0527% | $2.79 | 3 | 1 | <0.0001% |
HAMER JOHN | director | 128862 0.0444% | $2.79 | 0 | 2 | |
Stimart Tryn | Chief Legal Officer | 250 0.0001% | $2.79 | 1 | 1 | <0.0001% |
Falconer Ester | Chief Technology Officer | 0 0% | $2.79 | 0 | 1 |
Baker Bros Advisors LP | $124.69M | 9.36 | 27.53M | +20.15% | +$20.91M | 1.57 | |
Baillie Gifford Co | $105.01M | 7.88 | 23.18M | -3.6% | -$3.92M | 0.08 | |
Voya Investment Management LLC | $48.16M | 3.62 | 10.63M | +0.07% | +$36,008.97 | 0.05 | |
Capital World Investors | $37.83M | 2.84 | 8.35M | 0% | +$0 | 0.01 | |
Credit Suisse | $20.6M | 1.55 | 4.55M | -0.68% | -$140,135.55 | 0.02 | |
OrbiMed | $18.94M | 1.42 | 4.18M | 0% | +$0 | 0.39 | |
Arrowmark Colorado Holdings Llc | $18.6M | 1.4 | 4.11M | 0% | +$0 | 0.05 | |
BlackRock | $17.67M | 1.33 | 3.9M | -0.13% | -$23,324.97 | <0.0001 | |
Founders Fund | $17.09M | 1.28 | 3.77M | 0% | +$0 | 88.05 | |
Federated Hermes | $12.75M | 0.96 | 2.82M | -9.69% | -$1.37M | 0.03 | |
Casdin Capital | $10.69M | 0.8 | 2.36M | 0% | +$0 | 0.8 | |
LAZARD ASSET MANAGEMENT LLC | $9.15M | 0.69 | 2.02M | -40.8% | -$6.31M | 0.01 | |
Prosight Management Lp | $8.11M | 0.61 | 1.79M | +5.29% | +$407,700.00 | 2.26 | |
Guardian Capital Advisors LP | $7M | 0.61 | 1.79M | 0% | +$0 | 0.77 | |
Two Sigma Advisers LP | $7.96M | 0.6 | 1.76M | +76.95% | +$3.46M | 0.01 | |
Renaissance Technologies | $6.75M | 0.51 | 1.49M | +2.06% | +$136,354.99 | 0.01 | |
Two Sigma | $6.71M | 0.5 | 1.48M | +38.5% | +$1.86M | 0.01 | |
Millennium Management LLC | $5.74M | 0.43 | 1.27M | +1.02% | +$57,979.47 | <0.01 | |
Novo Holdings A/S | $5.1M | 0.38 | 1.13M | 0% | +$0 | 0.36 | |
Man Group Plc | $3.5M | 0.26 | 771,934 | New | +$3.5M | 0.01 | |
Citadel Advisors LLC | $3.46M | 0.26 | 764,833 | +32.25% | +$844,967.19 | <0.01 | |
Intellectus Partners | $2.45M | 0.18 | 541,783 | -38.94% | -$1.57M | 0.66 | |
ExodusPoint Capital Management, LP | $2.25M | 0.17 | 496,012 | +271.12% | +$1.64M | 0.03 | |
D. E. Shaw & Co. | $2.05M | 0.15 | 453,235 | +1,379.57% | +$1.91M | <0.01 | |
State Street | $2.04M | 0.15 | 450,255 | -2.31% | -$48,221.85 | <0.0001 | |
Founders Fund Growth Management Llc | $1.84M | 0.14 | 407,017 | 0% | +$0 | 2.94 | |
Royal Bank of Canada | $1.78M | 0.13 | 392,357 | +1.09% | +$19,194.07 | <0.0001 | |
Morgan Stanley | $1.77M | 0.13 | 390,139 | +3.52% | +$60,017.95 | <0.0001 | |
JPMorgan Chase | $1.68M | 0.13 | 370,765 | -9.41% | -$174,377.77 | <0.0001 | |
Ameriprise Financial | $1.31M | 0.1 | 289,836 | -0.02% | -$226.50 | <0.0001 | |
Geode Capital Management | $1.17M | 0.09 | 257,366 | +0.48% | +$5,535.65 | <0.0001 | |
Belmont Capital Group | $1.18M | 0.09 | 260,000 | -49.02% | -$1.13M | 0.32 | |
Commonwealth Of Pennsylvania Public School Empls Retrmt Sys | $1.13M | 0.09 | 250,248 | 0% | +$0 | 0.01 | |
PDT Partners | $1.12M | 0.08 | 247,478 | +0.04% | +$453.00 | 0.09 | |
Susquehanna International Group | $1.01M | 0.08 | 222,058 | -33.91% | -$516,121.15 | <0.01 | |
Jump Financial Llc | $1.01M | 0.08 | 221,913 | -10.37% | -$116,348.53 | 0.01 | |
Goldman Sachs | $935,114.00 | 0.07 | 206,427 | -65.67% | -$1.79M | <0.0001 | |
National Bank Of Canada Fi | $704,147.00 | 0.06 | 183,885 | +2,292.78% | +$674,718.99 | <0.01 | |
Dimensional Fund Advisors | $808,863.00 | 0.06 | 178,557 | +88.81% | +$380,474.60 | <0.0001 | |
Barclays | $780,000.00 | 0.06 | 172,358 | +42.85% | +$233,971.04 | <0.0001 | |
Bank of America | $711,586.00 | 0.05 | 157,083 | -8.41% | -$65,381.49 | <0.0001 | |
SEB | $682,069.00 | 0.05 | 150,567 | +64.79% | +$268,176.19 | <0.01 | |
Toronto-Dominion Bank | $634,200.00 | 0.05 | 140,000 | 0% | +$0 | <0.01 | |
Macquarie Group | $541,000.00 | 0.04 | 119,399 | 0% | +$0 | <0.0001 | |
American Century Investments | $531,478.00 | 0.04 | 117,324 | -0.2% | -$1,046.43 | <0.0001 | |
Polar Asset Management Partners Inc | $533,770.00 | 0.04 | 117,830 | 0% | +$0 | 0.01 | |
Archpoint Investors | $521,199.00 | 0.04 | 115,055 | 0% | +$0 | 0.23 | |
Stifel | $495,029.00 | 0.04 | 109,277 | -0.79% | -$3,932.07 | <0.01 | |
Advisor Group Holdings Inc | $474,932.00 | 0.04 | 104,847 | +2.63% | +$12,180.53 | <0.01 | |
UBS | $461,947.00 | 0.04 | 101,975 | +3,979% | +$450,621.99 | <0.0001 |